ClinicalTrials.gg
RecruitingNCT05622461Updated Jun 25, 2025

Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery

An interventional study of Road-to-recovery in Traumatic Brain Injury, Head Injury and Head Injuries, Closed, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-25.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study has two main goals: 1) to refine and enhance the R2R-TBI intervention; and 2) to examine the efficacy of the R2R-TBI intervention in a randomized control trial. To achieve the second goal, we will employ a between-groups randomized treatment design with repeated measures at baseline, one-month post-randomization, and at a six-month follow-up. The two conditions will be: a) usual medical care plus access to internet resources regarding pediatric brain injury (Internet Resources Comparison group, IRC), and b) usual medical care plus the R2R-TBI intervention (Road-to-Recovery group, R2R-TBI).

Read the detailed description

The early recovery period constitutes a critical window to set families on a positive road-to-recovery by supporting parental self-care, positive parent-child interactions, and awareness of potential longer-term concerns. The latter would facilitate parental recognition of behavioral and psychosocial needs that might otherwise go unmet.

Recognizing that (1) caregivers of children who have sustained TBI are at risk of worsening psychological health and that (2) caregiver functioning and parenting behaviors have a direct impact on child recovery and outcomes; intervening and supporting caregivers in the acute phase following injury may set children and families on a positive path to recovery. Intervening at the acute phase may reduce the cascading effects of parental burden/distress and concomitant negative parent-child interactions on child recovery and functioning over time.

Because families of children with TBI and other chronic health conditions may have difficulty accessing services due to transportation and cost issues, particularly lower income families, the R2R-TBI program is designed to be accessed via any web-enabled device (e.g., smartphone, computer, tablet) with any form of internet connection. We will also offer the intervention (via tablet) to parents while they wait for their child to complete outpatient therapies (e.g., speech, physical, and occupational therapy). Delivery of web-based behavioral health interventions may reduce barriers to help-seeking and promote evidence-based interventions that are both accessible and efficient.

02

Conditions studied

  • Traumatic Brain Injury
  • Head Injury
  • Head Injuries, Closed
  • Brain Hemorrhage, Traumatic
  • Brain Edema
  • Intracranial Edema
03

In context

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

This study's planned enrollment of 200 is above the median of 52 across 1,088 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Children's Hospital Medical Center, Cincinnati is the lead sponsor of 673 studies on the registry; 130 are open to participants now.

Of its 57 completed or terminated interventional studies of FDA-regulated products, 31 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Caregivers will be eligible if they are over 18 years of age, and if their child meets all of the following criteria:

  • Ages 3 months to 18 years at time of discharge from hospital
  • Sustained a complicated mild to severe TBI as defined by a Glasgow Coma Scale (GCS) of 13-15 with imagining abnormalities or GCS 3-12 with or without imaging abnormalities
  • Admitted overnight to the hospital
  • 0-3 months post-discharge

Exclusion criteria

Exclusion Criteria:

The caregiver will be excluded from participation if any of the following occur:

  • Child did not survive the injury
  • Child sustained a non-blunt head trauma (e.g. gunshot wound)
  • Child does not reside with parent/caregiver for study duration
  • English is not primary language spoken in the home
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Road-to-recovery group (R2R)

    Usual medical care plus the R2R-TBI intervention (self-guided web-program)

    Behavioral: Road-to-recovery

  • Active comparator
    Internet resources comparison group (IRC)

    Usual medical care plus internet resources

    Behavioral: Road-to-recovery

Interventions

  • BehavioralRoad-to-recovery

    R2R-TBI is a self-guided web-based intervention that targets caregiver psychological functioning, parenting behaviors, and family functioning in the first three months following pediatric traumatic brain injury.

06

What researchers measure

Primary outcomes

  1. Parent anxiety

    Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Measure 4a; scores range from 4-20 with higher score indicating greater symptoms of anxiety

    Time frame: Change from baseline at 4-6 weeks post-intervention

  2. Parent anxiety

    Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Measure 4a; scores range from 4-20 with higher score indicating greater symptoms of anxiety

    Time frame: Change from baseline at 6 months

  3. Parent depression

    Center for Epidemiological Studies Depression Scale (CES-D; 10-items); scores range from 0 -30 with higher scores indicating of higher levels of depressive symptomatology

    Time frame: Change from baseline at 4-6 weeks post-intervention

  4. Parent depression

    Center for Epidemiological Studies Depression Scale (CES-D; 10-items); scores range from 0 -30 with higher scores indicating of higher levels of depressive symptomatology

    Time frame: Change from baseline at 6 months

  5. Parenting self-efficacy

    Caregiver self-efficacy scale (CSES); scores range from 25-100, higher scores indicate greater parenting self efficacy

    Time frame: Change from baseline at 4-6 weeks post-intervention

  6. Parenting self-efficacy

    Caregiver self-efficacy scale (CSES); scores range from 25-100, higher scores indicate greater parenting self efficacy

    Time frame: Change from baseline at 6 months

  7. Parent post-traumatic symptoms

    Primary Care PTSD Screen for DSM-5 (PC-PTSD-5); scores rage from 0-5 with higher scores indicating greater experience of post-traumatic stress symptoms

    Time frame: Change from baseline at 4-6 weeks post-intervention

  8. Parent post-traumatic symptoms

    Primary Care PTSD Screen for DSM-5 (PC-PTSD-5); scores rage from 0-5 with higher scores indicating greater experience of post-traumatic stress symptoms

    Time frame: Change from baseline at 6 months

Secondary outcomes

  1. Family Functioning

    Family Assessment Device - Global Functioning Scale. Scores range from 1 to 4 with higher scores indicating poorer family functioning

    Time frame: Change from baseline at 4-6 weeks post-intervention

  2. Family Functioning

    Family Assessment Device - Global Functioning Scale. Scores range from 1 to 4 with higher scores indicating poorer family functioning

    Time frame: Change from baseline at 6 months

  3. Family Burden of Injury

    Family Burden of Injury Interview (FBII). Average scores range from 0-4; higher scores indicate greater injury-related burden

    Time frame: Change from baseline at 4-6 weeks post-intervention

  4. Family Burden of Injury

    Family Burden of Injury Interview (FBII). Average scores range from 0-4; higher scores indicate greater injury-related burden

    Time frame: Change from baseline at 6 months

  5. Child Socioemotional Functioning

    Pediatric Quality of Life Scale (PEDS-QL) - Psychosocial Health Summary Score (score range varies based on child age; higher scores indicate greater health related quality of life)

    Time frame: Change from baseline at 4-6 weeks post-intervention

  6. Child Socioemotional Functioning

    Pediatric Quality of Life Scale (PEDS-QL) - Psychosocial Health Summary Score (score range varies based on child age; higher scores indicate greater health related quality of life)

    Time frame: Change from baseline at 6 months

  7. Parent mindful self-care

    Mindful self-care scale (MSCS); scores range from 6 - 30, higher scores denote greater frequency in engaging in self-care behaviors

    Time frame: Change from baseline at 4-6 weeks post-intervention

  8. Parent mindful self-care

    Mindful self-care scale (MSCS); scores range from 6 - 30, higher scores denote greater frequency in engaging in self-care behaviors

    Time frame: Change from baseline at 6 months

  9. Parent resilience

    Connor-Davidson Resilience Scale (CDRI); scores range from 0-40 with higher scored indicating greater resilience

    Time frame: Change from baseline at 4-6 weeks post-intervention

  10. Parent resilience

    Connor-Davidson Resilience Scale (CDRI); scores range from 0-40 with higher scored indicating greater resilience

    Time frame: Change from baseline at 6 months

Other outcomes

  1. Moderators of treatment effects

    Examining household income and baseline caregiver distress as moderator of treatment effects

    Time frame: 4-6 weeks

  2. Moderators of treatment effects

    Examining household income and baseline caregiver distress as moderator of treatment effects

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Plan is to share deidentified data as consistent with requirement of funding source (i.e., The National Institute on Disability and Rehabilitation Research).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Starting 6 months after publication

Access criteria: Plan is to share deidentified data as consistent with protocols of funding source (i.e., The National Institute on Disability and Rehabilitation Research).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2023 (actual). Primary completion is estimated for Mar 2026, 36 months after the start.

Of 442 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 36 months is below that.

Counting every sponsor, half of 464 studies reached it within 40 months; a quarter within 22 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2022
First posted
Nov 18, 2022
StartActual
Feb 13, 2023
Primary completionEst.
Mar 1, 2026
CompletionEst.
Aug 31, 2026
Last update
Jun 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05622461
Responsible party
Sponsor
First posted
Nov 18, 2022
Start date
Feb 13, 2023
Primary completion
Mar 1, 2026 (estimated)
Completion
Aug 31, 2026 (estimated)
Last update
Jun 25, 2025

Study contacts

Shari Wade, PhD
Contact
Shari.Wade@cchmc.org
5134610952
Stacey Raj
Contact
rajs@xavier.edu
Shari Wade, PhD
principal investigator · CCHMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion